Cost-effectiveness of extracorporeal cardiopulmonary resuscitation vs. conventional cardiopulmonary resuscitation in out-of-hospital cardiac arrest: a pre-planned, trial-based economic evaluation
European Heart Journal: Acute Cardiovascular Care · 2024
DOI: 10.1093/ehjacc/zuae050 ↗Kurz gefasst
Multizentrische Studie in der Zeitschrift European Heart Journal: Acute Cardiovascular Care, 2024. Verfasst von Thijs S R Delnoij und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Intensive Care Medicine, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands. Hauptthemen laut MEDLINE: Cardiopulmonary Resuscitation, Cost-Benefit Analysis, Out-of-Hospital Cardiac Arrest, Quality of Life. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Netherlands Organization for Health Research and Development, Maquet Cardiopulmonary.
Themen: Reanimation
Abstract (Originalsprache)
Aims
When out-of-hospital cardiac arrest (OHCA) becomes refractory, extracorporeal cardiopulmonary resuscitation (ECPR) is a potential option to restore circulation and improve the patient’s outcome. However, ECPR requires specific materials and highly skilled personnel, and it is unclear whether increased survival and health-related quality of life (HRQOL) justify these costs. Methods and results This cost-effectiveness study was part of the INCEPTION study, a multi-centre, pragmatic randomized trial comparing hospital-based ECPR to conventional CPR (CCPR) in patients with refractory OHCA in 10 cardiosurgical centres in the Netherlands. We analysed healthcare costs in the first year and measured HRQOL using the EQ-5D-5L at 1, 3, 6, and 12 months. Incremental cost-effectiveness ratios (ICERs), cost-effectiveness planes, and acceptability curves were calculated. Sensitivity analyses were performed for per-protocol and as-treated subgroups as well as imputed productivity loss in deceased patients. In total, 132 patients were enrolled: 62 in the CCPR and 70 in the ECPR group. The difference in mean costs after 1 year was €5109 (95% confidence interval −7264 to 15 764). Mean quality-adjusted life year (QALY) after 1 year was 0.15 in the ECPR group and 0.11 in the CCPR group, resulting in an ICER of €121 643 per additional QALY gained. The acceptability curve shows that at a willingness-to-pay threshold of €80.000, the probability of ECPR being cost-effective compared with CCPR is 36%. Sensitivity analysis showed increasing ICER in the per-protocol and as-treated groups and lower probabilities of acceptance.
Conclusion
Hospital-based ECPR in refractory OHCA has a low probability of being cost-effective in a trial-based economic evaluation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Intensive Care Medicine, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.
- Department of Cardiology, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.
- Department of Clinical Epidemiology and Medical Technical Assessment, Maastricht University Medical Center, Maastricht, The Netherlands.
- Department of Cardiology, Isala Hospital, Zwolle, The Netherlands.
- Department of Intensive Care Medicine, Catharina Hospital, Eindhoven, The Netherlands.
- Department of Intensive Care Medicine, Leiden University Medical Center, Leiden, The Netherlands.
ORCID-Profile: Thijs S R Delnoij, Corstiaan den Uil, Jos G Maessen
Förderung
- Netherlands Organization for Health Research and Development
- Maquet Cardiopulmonary
Zitieren
APA
Delnoij, T. S. R., Suverein, M. M., Essers, B. A. B., Hermanides, R. C., Otterspoor, L., Elzo Kraemer, C. V., Vlaar, A. P. J., van der Heijden, J. J., Scholten, E., den Uil, C., Akin, S., de Metz, J., van der Horst, I. C. C., Maessen, J. G., Lorusso, R., van de Poll, M. C. G., & INCEPTION-investigators (2024). Cost-effectiveness of extracorporeal cardiopulmonary resuscitation vs. conventional cardiopulmonary resuscitation in out-of-hospital cardiac arrest: a pre-planned, trial-based economic evaluation. European Heart Journal: Acute Cardiovascular Care. https://doi.org/10.1093/ehjacc/zuae050
Vancouver
Delnoij TSR, Suverein MM, Essers BAB, Hermanides RC, Otterspoor L, Elzo Kraemer CV, et al. Cost-effectiveness of extracorporeal cardiopulmonary resuscitation vs. conventional cardiopulmonary resuscitation in out-of-hospital cardiac arrest: a pre-planned, trial-based economic evaluation. European Heart Journal: Acute Cardiovascular Care. 2024. doi:10.1093/ehjacc/zuae050
BibTeX
@article{Delnoij2024,
author = {Delnoij, Thijs S R and Suverein, Martje M and Essers, Brigitte A B and Hermanides, Renicus C and Otterspoor, Luuk and Elzo Kraemer, Carlos V and Vlaar, Alexander P J and van der Heijden, Joris J and Scholten, Erik and den Uil, Corstiaan and Akin, Sakir and de Metz, Jesse and van der Horst, Iwan C C and Maessen, Jos G and Lorusso, Roberto and van de Poll, Marcel C G and INCEPTION-investigators, INCEPTION-investigators},
title = {Cost-effectiveness of extracorporeal cardiopulmonary resuscitation vs. conventional cardiopulmonary resuscitation in out-of-hospital cardiac arrest: a pre-planned, trial-based economic evaluation},
journal = {European Heart Journal: Acute Cardiovascular Care},
year = {2024},
doi = {10.1093/ehjacc/zuae050}
}
EUVIMED